JVCKENWOOD to Sell 3D Cell Culture Multi-Well Plate for Drug Discovery Through Marketing Alliance with HCS Pharma
JVCKENWOOD Corporation ("JVCKENWOOD") has concluded a marketing alliance with HCS Pharma ("HCS"), a French start-up company, to sell multi-well plates for 3D cell culture in Japan and some parts of Asia that contribute to the drug discovery. - December 02, 2021
HCS Pharma Opens Representative Office in Taiwan and Joins National Health Research Institutes Incubator
Biotech startup HCS Pharmais entering into incubation at the prestigious NHRI (National Health Research Institutes) in Taiwan. There, it will develop collaborations to put its exclusive BIOMIMESYS® technology at the service of the country's four major scientific research institutions. HCS Pharma has also opened a representative office in Taiwan, headed by Joseph Chou. - August 19, 2021
HCS Pharma Secures 20 Million EUR Capital Commitment from the GEM Group for the Development of BIOMIMESYS® Products
HCS Pharma announced today that it has signed an agreement with GEM Global Yield LLC SCS ("GEM") a Luxemburg-based private alternative investment group for a EUR 20 million capital commitment. - August 04, 2021